You can buy or sell SONN and other stocks, options, ETFs, and crypto commission-free!
Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Read More The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey.
Princeton, New Jersey
52 Week High
52 Week Low